Scheme 1From: Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapySchematic illustration of tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapyBack to article page